Back
Arbutus Biopharma Stock Price Chart
Sponsored
ABUS
Sponsored
2025 Gold Forecast: A Perfect Storm for Demand
Discover our Gold Price Outlook for 2025--FREE--here
Sell
30
ABUS
Arbutus Biopharma
Last Price:
$3.22
Seasonality Move:
21.65%
7 Day Trial
ALL ACCESS PASS
$
7
FREE REPORT: 2025 Gold Price Outlook
Get Your Copy of "2025 Gold Forecast: A Perfect Storm for Demand" Here.-
The current trend is relatively stagnant and ABUS is experiencing slight buying pressure.
Arbutus Biopharma Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 3.27 | Sell |
20-day SMA: | 3.46 | Sell |
50-day SMA: | 3.67 | Sell |
200-day SMA: | 3.45 | Sell |
8-day EMA: | 3.27 | Sell |
20-day EMA: | 3.41 | Sell |
50-day EMA: | 3.58 | Sell |
200-day EMA: | 3.43 | Sell |
Arbutus Biopharma Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.13 | Sell |
Relative Strength Index (14 RSI): | 33.52 | Sell |
Chaikin Money Flow: | 367268 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (3.28 - 3.64) | Sell |
Bollinger Bands (100): | (3.49 - 4.11) | Sell |
Arbutus Biopharma Technical Analysis
Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 23 | Dec 24 | Dec 26 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
12 | 13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | 26 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Arbutus Biopharma Stock
Is Arbutus Biopharma Stock a Buy?
-
Arbutus Biopharma share price is 3.19 while ABUS 8-day simple moving average is 3.27, which is a Sell signal.
-
The stock price of ABUS is 3.19 while Arbutus Biopharma 20-day SMA is 3.46, which makes it a Sell.
-
Arbutus Biopharma 50-day simple moving average is 3.67 while ABUS share price is 3.19, making it a Sell technically.
-
ABUS stock price is 3.19 and Arbutus Biopharma 200-day simple moving average is 3.45, creating a Sell signal.
ABUS Technical Analysis vs Fundamental Analysis
Sell
30
Arbutus Biopharma (ABUS)
is a Sell
Is Arbutus Biopharma a Buy or a Sell?
-
Arbutus Biopharma stock is rated a SellThe current Arbutus Biopharma [ABUS] share price is $3.19. The Score for ABUS is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
Arbutus Biopharma Stock Info
Market Cap:
604.5M
Price in USD:
3.19
Share Volume:
787K
Arbutus Biopharma 52-Week Range
52-Week High:
4.73
52-Week Low:
2.21
Sell
30
Arbutus Biopharma (ABUS)
is a Sell
Arbutus Biopharma Share Price Forecast
-
What is the Arbutus Biopharma stock price today?The Arbutus Biopharma stock price is 3.19 USD today.
-
Will ABUS stock go up or go down?Arbutus Biopharma> share price is forecast to RISE/FALL based on technical indicators
-
Is Arbutus Biopharma overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Arbutus Biopharma is overvalued.
Is Arbutus Biopharma Stock a Buy?
-
Arbutus Biopharma share price is 3.19 while ABUS 8-day exponential moving average is 3.27, which is a Sell signal.
-
The stock price of ABUS is 3.19 while Arbutus Biopharma 20-day EMA is 3.41, which makes it a Sell.
-
Arbutus Biopharma 50-day exponential moving average is 3.58 while ABUS share price is 3.19, making it a Sell technically.
-
ABUS stock price is 3.19 and Arbutus Biopharma 200-day simple moving average is 3.43, creating a Sell signal.
Fundamental Analysis of Arbutus Biopharma
Is Arbutus Biopharma a good investment?
-
Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.06 per share, and an increase next year of $0.04 per share.
Technical Analysis of Arbutus Biopharma
Should I short Arbutus Biopharma stock?
-
ABUS Moving Average Covergence Divergence (MACD) indicator is -0.13, suggesting Arbutus Biopharma is a Sell
-
Arbutus Biopharma Relative Strength Index (RSI) is 33.52, which suggest Arbutus Biopharma is oversold
-
The Bollinger Bands (25) for Arbutus Biopharma is (3.28 - 3.64), which suggest Arbutus Biopharma is a Sell
-
The Bollinger Bands (100) for Arbutus Biopharma is (3.49 - 4.11), which suggest Arbutus Biopharma is a Sell
* Arbutus Biopharma stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.